Search

Author/Creator Fowler, Nathan H

2. Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial. Issue 2 (February 2019)

Authors:
Nastoupil, Loretta J; Lunning, Matthew A; Vose, Julie M; Schreeder, Marshall T; Siddiqi, Tanya; Flowers, Christopher R; Cohen, Jonathon B; Burger, Jan A; Wierda, William G; O'Brien, Susan; Sportelli, Peter; Miskin, Hari P; Purdom, Michelle A; Weiss, Michael S; Fowler, Nathan H
Journal:
Lancet
Issue:
Volume 6:Issue 2(2019)
Page Start:
e100
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search